Mo. Babawale et al., Effects of gestational diabetes on junctional adhesion molecules in human term placental vasculature, DIABETOLOG, 43(9), 2000, pp. 1185-1196
Aims/hypothesis. The aim of this study was to investigate whether gestation
al diabetes mellitus, which occurs in the microvascular remodelling phase o
f placental development, causes alterations in surface expression of tight
and adherens junctional molecules involved in endothelial barrier function
and angiogenesis.
Methods. Term placenta, delivered by elective Caesarian section, from norma
l pregnancy (n = 5) and those complicated by gestational diabetes (n = 5) w
ere perfusion-fixed and analysed by indirect immunofluorescence and confoca
l scanning microscopy. Using systematic random sampling, the surface expres
sion of endothelial junctional proteins and the relative incidences of immu
nostained vessels were compared between the two study groups. Total vessel
lengths were measured by stereological techniques.
Results. The adherens junctional molecules, vascular-endothelial cadherin a
nd beta-catenin, and the tight junctional molecules, occludin and zonula oc
cludens-1 were localised to paracellular clefts in both study groups. The d
iabetic placentae showed pronounced reductions in the intensity of immunofl
uorescence and in the number of immune-positive vessels. A corresponding st
atistically significant increase (from 19% to 56%) in the percentage of ves
sels showing junctional anti-phosphotyrosine immunoreactivity was found. Th
e differences observed represented real changes in the absolute lengths of
immunostained regions along the vessels. The stereological measurements fai
led to detect any statistically significant change in the combined length o
f fetal vessels in gestational diabetic placenta.
Conclusion/interpretation. Our results suggest that even short duration dia
betic insult, alters the surface expression of placental junctional protein
s. This alteration could be mediated by the tyrosine-phosphorylation pathwa
y. The changes suggest impaired barrier function rather than accelerated va
scular growth.